Mechanistic rationale for factor XIII cotreatment in haemophilia

Joan D. Beckman; Alisa S. Wolberg

doi:10.1111/hae.13855

Mechanistic rationale for factor XIII cotreatment in haemophilia

Joan D. Beckman, Alisa S. Wolberg

Medicine - Hematology, Oncology, Transplant

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	e377-e378
Journal	Haemophilia
Volume	25
Issue number	6
DOIs	https://doi.org/10.1111/hae.13855
State	Published - Nov 1 2019

Bibliographical note

Funding Information:
Work discussed in this letter was supported by research funding from the National Institutes of Health (R01HL126974 to ASW and T32HL007149 to the University of North Carolina and JDB) and a 2016 Mentored Research Award from the Hemostasis and Thrombosis Research Society (HTRS) to JDB which was sponsored by an educational grant to HTRS from CSL Behring.

Access

10.1111/hae.13855

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032044

OpenUrl availability

Full text

Cite this

@article{1275a3b57862491bbe539b4860c6a29d,

title = "Mechanistic rationale for factor XIII cotreatment in haemophilia",

author = "Beckman, {Joan D.} and Wolberg, {Alisa S.}",

note = "Funding Information: Work discussed in this letter was supported by research funding from the National Institutes of Health (R01HL126974 to ASW and T32HL007149 to the University of North Carolina and JDB) and a 2016 Mentored Research Award from the Hemostasis and Thrombosis Research Society (HTRS) to JDB which was sponsored by an educational grant to HTRS from CSL Behring.",

year = "2019",

month = nov,

day = "1",

doi = "10.1111/hae.13855",

language = "English (US)",

volume = "25",

pages = "e377--e378",

journal = "Haemophilia",

issn = "1351-8216",

publisher = "Wiley-Blackwell",

number = "6",

}

TY - JOUR

T1 - Mechanistic rationale for factor XIII cotreatment in haemophilia

AU - Beckman, Joan D.

AU - Wolberg, Alisa S.

N1 - Funding Information: Work discussed in this letter was supported by research funding from the National Institutes of Health (R01HL126974 to ASW and T32HL007149 to the University of North Carolina and JDB) and a 2016 Mentored Research Award from the Hemostasis and Thrombosis Research Society (HTRS) to JDB which was sponsored by an educational grant to HTRS from CSL Behring.

PY - 2019/11/1

Y1 - 2019/11/1

UR - http://www.scopus.com/inward/record.url?scp=85073954249&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073954249&partnerID=8YFLogxK

U2 - 10.1111/hae.13855

DO - 10.1111/hae.13855

M3 - Article

C2 - 31577382

AN - SCOPUS:85073954249

SN - 1351-8216

VL - 25

SP - e377-e378

JO - Haemophilia

JF - Haemophilia

IS - 6

ER -

Mechanistic rationale for factor XIII cotreatment in haemophilia

Bibliographical note

Access

OpenUrl availability

Other files and links

Cite this